ibuprofen has been researched along with glycine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Darsee, JR; Kloner, RA | 1 |
Corrigan, OI; Lane, ME; Levis, K; McDonald, GS | 1 |
Chatterjee, N; Daugherty, SE; Fallin, MD; Hayes, RB; Huang, WY; Isaacs, WB; Platz, EA; Shugart, YY; Welch, R | 1 |
Brodin, B; Nielsen, CU; Omkvist, DH | 1 |
Di Nardo, G; Gilardi, G; Goyal, A; Sideri, A; Tsotsou, GE | 1 |
Fink, G; Martineau, C; Steuernagel, S; Suzuki, K; Taulelle, F | 1 |
Leão, RM; Zugaib, J | 2 |
1 trial(s) available for ibuprofen and glycine
Article | Year |
---|---|
Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Topics: Adenoma; Aged; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Case-Control Studies; Colonic Neoplasms; Female; Genetic Variation; Genotype; Glutamic Acid; Glycine; Haplotypes; Humans; Ibuprofen; Leucine; Lysine; Male; Methionine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Racemases and Epimerases; Rectal Neoplasms; Serine; Valine | 2007 |
10 other study(ies) available for ibuprofen and glycine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Dependency of location of salvageable myocardium on type of intervention.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Female; Flurbiprofen; Glycine; Heart; Ibuprofen; Male; Myocardial Infarction; Myocardium; Necrosis; Risk | 1981 |
Comparative assessment of two indices of drug induced permeability changes in the perfused rat intestine.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Glycine; Ibuprofen; In Vitro Techniques; Intestinal Mucosa; Intestines; Ketoprofen; Naproxen; Permeability; Phenylalanine; Polyethylene Glycols; Rats | 2006 |
Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Topics: Animals; Biological Transport; Caco-2 Cells; Cell Line; Cell Line, Transformed; Dipeptides; Dogs; Drug Interactions; Glycine; Humans; Ibuprofen; Methylglucosides; Peptide Transporter 1; Symporters | 2010 |
Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide.
Topics: Asparagine; Bacillus megaterium; Catalysis; Cytochrome P-450 Enzyme System; Diclofenac; Drug Discovery; Escherichia coli; Glutamine; Glycine; Histidine; Humans; Hydroxylation; Ibuprofen; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Tolbutamide | 2012 |
Hartmann-Hahn 2D-map to optimize the RAMP-CPMAS NMR experiment for pharmaceutical materials.
Topics: Adamantane; Data Interpretation, Statistical; Glycine; Ibuprofen; Nuclear Magnetic Resonance, Biomolecular; Protons; Radio Waves; Signal-To-Noise Ratio | 2012 |
Inhibitors of oxidative and hydrolytic endocannabinoid degradation do not enhance depolarization-induced suppression of excitation on dorsal cochlear nucleus glycinergic neurons.
Topics: Animals; Calcium; Cochlear Nucleus; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Endocannabinoids; Glycine; Ibuprofen; Indomethacin; Male; Neuronal Plasticity; Neurons; Rats; Rats, Wistar; Salicylates; Synaptic Potentials | 2017 |
Enhancement of Endocannabinoid-dependent Depolarization-induced Suppression of Excitation in Glycinergic Neurons by Prolonged Exposure to High Doses of Salicylate.
Topics: Animals; Calcium; Cochlear Nucleus; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endocannabinoids; Glycine; Ibuprofen; Male; Neurons; Rats, Wistar; Receptor, Cannabinoid, CB1; Sodium Salicylate; Synapses; Tinnitus; Tissue Culture Techniques | 2018 |